Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder

By  

Current Neuropharmacology, Vol. 15, Iss. 7, 2017-08 ,pp. : 977-995

Bentham Science Publishers

Access to resources Recommend Favorite

Neurobiological Evidence Supporting Glutamate's Role in Pediatric Obsessive Compulsive Disorder

By  

Child and Adolescent Psychopharmacology News, Vol. 15, Iss. 6, 2010-12 ,pp. : 6-10

Guilford Publications Inc

Access to resources Recommend Favorite

Past, Present and Future Drugs for the Treatment of Obsessive- Compulsive Disorder

By  

Current Medicinal Chemistry, Vol. 17, Iss. 29, 2010-10 ,pp. : 3410-3421

Bentham Science Publishers

Access to resources Recommend Favorite

Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study

By Arnold Paul   Rosenberg David   Mundo Emanuela   Tharmalingam Subi   Kennedy James   Richter Margaret  

Psychopharmacology, Vol. 174, Iss. 4, 2004-08 ,pp. : 530-538

Springer Publishing Company

Access to resources Recommend Favorite

Advances in the pharmacotherapy of obsessive-compulsive disorder

By Bisserbe J.C.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 260-260

Elsevier

Access to resources Recommend Favorite